Kernkompetenzen

• Benignes Prostatasyndrom (BPS)
• Endourologische Operative Therapie
• Urolithiasis
• Urologie der Frau

Werdegang

Seit 01/2022 Ärztlicher Leiter Praxisklinik „Urologie-Süd“
07/2010-12/2021 Chefarzt der Urologischen Klinik München-Harlaching
01/2007-06/2010 Stellvertretender Klinikdirektor und Leitender Oberarzt der Urologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München
02/2003-12/2006 Oberarzt der Urologischen Klinik der LMU München
12/2001 Facharzt für Urologie
12/1994-12/1995 Praktisches Jahr in St. Gallen, Zürich, San Francisco und München
04/1996-07/1997 Assistenzarzt an der Urologischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. D. Ackermann)
08/1997-07/1998 Assistenzarzt an der Chirurgischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. J. Lange)
08/1998-08/1999 Wissenschaftlicher Angestellter an der Urologischen Klinik der Gutenberg-Universität Mainz (Prof. Dr. J. Thüroff)
08/1999-01/2003 Wissenschaftlicher Mitarbeiter der Urologischen Klinik der LMU München (Prof. Dr. Dr. hc. mult. A Hofstetter)

Mitgliedschaften

• Deutsche Gesellschaft für Urologie (DGU)
• European Association of Urologie (EAU)
• Bayerische Urologenvereinigung (BUV)
• Urological Research Society (URS)

Wissenschaftliche Publikationen

Faul P, Farin G, Reich O, Steude U
The „Band-Electrode“: First Experiences with a novel TURP Procedure to improve Hemostasis.
European Urology; 30(3): 403-408, 1996 (IF 6,512)

Faul P, Farin G, Reich O
Improvement of hemostasis during TUR-P by a modified resection -technique and -electrode (bandloop).
Urologe; 37: 569-576, 1997 (IF 0,391)

Corvin S, Liedl B, Adam C, Zaak D, Reich O, Stürminger P, Hofstetter A
Simultaneous Microsurgical Spermatic Vein Ligation and Sclerotherapy: A combined procedure for the treatment of recurrent or persistent varicocele.
European Urology; 40(3): 350-3, 2001 (IF 6,512)

Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A
In-vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP) and vaporization-resection of the prostate (TUVRP)
Urological Research; 30:15-20, 2002 (IF 1,615)

Corvin S, Schneede P, Siakavara E, Frimberger D, Zaak D, Siebels M, Reich O, Hofstetter A
Interstitial laser coagulation combined with minimal transurethral resection of the prostate for the treatment of benign prostatic hyperplasia.
Journal of Endourology; 16(6):387-90, 2002 (IF 1,930)

Reich O, Schneede P, Zaak D, Siebels M, Hofstetter A
Ex-vivo-comparison of the hemostatic properties of transurethral resection of the prostate (TURP) and transurethral vaporization of the prostate (TUVRP)
British Journal of Urology International; 92(3): 319-22, 2003 (IF 2,704)

Reich O, Schneede P, Mseddi A, Zaak D, Siebels M, Hofstetter A
Argon Plasma Coagulation for endourological procedures: ex-vivo evaluations of hemostatic properties.
European Urology; 44(2): 272-6, 2003 (IF 6,512)

Reich O, Schneede P, Corvin S, Zaak D, Sroka R, Hofstetter A
Combination of Interstitial Laser Coagulation (ILC) and Transurethral Resection of the Prostate (TURP): Ex-vivo-evaluations
Urology; 61(6): 1172-76, 2003 (IF 2,242)

Reich O, Hungerhuber E, Hofstetter A, Siebels M, Gusbeth G, Schneede P
Fluorescence guided laser therapy of urethral warts.
Medical Laser Application; 18(2): 117-22, 2003

Zaak D, Sroka R, Höppner M, Khoder W, Reich O, Tritschler S, Muschter R, Knüchel R, Hofstetter A
Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer – preliminary results.
Medical Laser Application; 18(1): 91-95, 2003

Zaak D, Sroka R, Stocker S, Bise K, Lein M, Höppner M, Frimberger D, Schneede P, Reich O, Kriegmair M, Knüchel R, Baumgartner R, Hofstetter A
Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX – in-vivo experiments on the dunning rat tumor model.
Urologia Internationalis; 72(3):196-202, 2004 (IF 0,891)

Reich O, Faul P
The band electrode: Ongoing experience with a novel TURP loop to improve hemostasis in 265 patients.
Urologia Internationalis; 71(1): 40-45, 2004 (IF 0,891)

Siebels M, Theodorakis J, Schmeller N, Corvin S, Mistry-Burchardi N, Hillebrand G, Frimberger D, Reich O, Land W, Hofstetter A
Risks and complications in 160 living kidney donors who underwent nephroureterectomy
Nephrology Dialysis Transplantation; 18(12): 2648-54, 2003 (IF 3,568)

Reich O, Mseddi A, Zaak D, Trottmann M, Hungerhuber E, Schneede P
The use of argon plasma coagulation (APC) in endourology: In-vitro experiments
Urology; 63(2): 387-91, 2004 (IF 2,242)

Reich O, Michel MS, Schneede P, Liedl B, Hofstetter A
Durability of probes for Interstitial Laser Coagulation (ILC): Impact of power setting and probe design
Journal of Endourology; 18(3): 299-302, 2004 (IF 1,930)

Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A
Experimental comparison of high power (80W) Potassium Titanyl Phosphate (KTP) Laser Vaporization and Transurethral Resection of the Prostate
Journal of Urology; 171(6): 2502-2504, 2004 (IF 3,952)

Bachmann A, Reich O, Wyler S, Ruszat R, Casella R, Gasser T, Sulser T
The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures.
Urologe A; 43(10):1262-1270, 2004 (IF 0,391)

Wendt-Nordahl G, Hacker A, Reich O, Djavan B, Alken P, Michel MS
The Vista System: A New Bipolar Resection Device for Endourological Procedures: Comparison with Conventional Resectoscope.
European Urology; 46(5): 586-590, 2004 (IF 6,512)

Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann A
Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures.
Journal of Endourology; 18(10): 976-981, 2004 (IF 1,930)

Reich O, Bachmann A, Siebels M, Hofstetter A, Stief C, Sulser T
High Power (80W) Potassium-Titanyl-Phosphate (KTP) Laser Vaporization Of The Prostate In 66 High Risk Patients.
Journal of Urology; 173(1): 158-160, 2005 (IF 3,952)

Bachmann A, Sulser T, Jayet C, Wyler S, Ruszat R, Reich O, Gasser TC, Siebels M, Stief CG, Casella R
Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5mm ultrathin cryoprobes: a preliminary report.
European Urology; 47(4): 474-479, 2005 (IF 6,512)

Bachmann A, Giannini O, Wolff T, Dickenmann M, Ruszat R, Langer I, Gurke L, Gasser TC, Reich O, Stief CG, Steiger J, Sulser T
Retroperitoneoscopic living donor nephrectomy: a comparison with the open approach in respect of early postoperative pain management.
Transplant Proc; 37(2): 609-612, 2005 (IF 1,055)

Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T.
Photoselective vaporization of the prostate: the Basel experience after 108 procedures.
European Urology; 47(6): 798-804, 2005 (IF 6,512)

Wendt-Nordahl G, Hacker A, Fastenmeier K, Knoll T, Reich O, Alken P, Michel MS
New Bipolar Resection Device for Transurethral Resection of the Prostate: First ex-Vivo and in-Vivo Evaluation
Journal of Endourology; 19(10): 1203-1209, 2005 (IF 1,930)

Reich O, Noll M, Gratzke C, Bachmann A, Waidelich R, Seitz M, Schlenker B, Baumgartner R, Hofstetter A,  Stief CG
A high-level virtual reality simulator for endourological procedures of the lower urinary tract
Urology; 67(6): 1144-1448, 2006 (IF 2,242)

Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG
Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy
European Urology; 49(6):1075-1078, 2006 (IF 6,512)

Ruszat R, Wyler S, Seifert HH, Reich O, Forster T, Stief  CG, Sulser T, Bachmann A
Photoselective vaporization of the prostate: Experience with prostate adenomas >80 ccm
Urologe A; 45(7): 858-864, 2006 (IF 0,391)

Ruszat R, Wyler S, Seifert H, Reich O, Forster T, Leippold T, Sulser T, Bachmann A
Photoselective vaporization of the prostate: Subgroup analysis of men with refractory urinary retention
European Urology; 50(5): 1040-1049, 2006 (IF 6,512)

Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A
Safety and Effectiveness of Photoselective Vaporization of the Prostate (PVP) in Patients on Ongoing Oral Anticoagulation
European Urology; 51(4): 1031-1038, 2007 (IF 6,512)

Gratzke C, Ückert S, Kedia G, Reich O, Schlenker B, Seitz M, Stief CG
In vitro effects of PDE-5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach
Urological Research; 35(1): 49-54, 2007 (IF 1,615)

Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek PH, Lack N, Stief CG, Reich O
Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study
Journal of Urology; 177(4): 1419-1422, 2007 (IF 3,952)

Bader M, Hecht V, Hocaoglu Y, Staehler M, Reich O, Stief C, Sroka R
Technical aspects of intraoperative assessment of treatment progress in laser lithotripsy
Urologe A; 46(9): 1019-1026, 2007 (IF 0,391)

Gratzke C, Ückert S, Reich O, Schlenker B, Tilki D, Seitz M, Stief CG
PDE5 inhibitors: A new option in the treatment of ureteral colic ?
Urologe A; 46(9): 1219-1223, 2007 (IF 0,391)

Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, Tilki D, Bachmann A, Stief CG, Reich O
The Diode laser: A novel side-fire approach for laser vaporisation of the human prostate – Immediate efficacy and 1-year follow-up
European Urology; 52(6): 1717-1722, 2007 (IF 6,512)

Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R
Diode laser: Ex-vivo studies on vaporization and coagulation characteristics
Urologe A; 46(9): 1242-1247, 2007 (IF 0,391)

Bader MJ, Hecht V, Hocaoglu Y, Tilki D, Staehler M, Wondrazek F, Reich O, Stief CG, Sroka R
In-vitro comparison of laser-induced lithotripsy on artificial stones by means of different laser systems
Medical Laser Application; 22(4): 220-26, 2008

Sroka R, Ackermann A, Tilki D, Reich O, Steinbrecher V, Hofstetter A, Stief CG, Seitz M
In-vitro comparison of the tissue vaporisation capabilities of different lasers.
Medical Laser Application; 22(4): 227-31, 2008

Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knüchel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief C
Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid – First clinical experiences
Urology; 72(2): 345-348,2008 (IF 2,242)

Ruszat R, Seitz M, Wyler SF, Abe C, Riecken M, Reich O, Gasser TC, Bachmann A
Greenlight Laservaporization of the Prostate: Single-center experience and log-term results after 500 procedures
European Urology; 54(4): 893-901, 2008 (IF 6,512)

Tilki D, Kilic N, Herbst H, Reich O, Seitz M, Lauke H, Stief C, Ergün S
High level of endostatin in epididymal epithelium: Protection against primary malignancies in this organ ?
Histochem Cell Biol; 130(3): 527-535, 2008 (IF 2,320)

Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek PH, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance
Morbidity, mortality and early outcome of transurethral resection of the prostate: A multicenter evaluation of 10654 patients
Journal of Urology; 180(1): 246-249, 2008 (IF 3,952)

Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Riecken M, Reich O, Gasser TC, Bachmann A
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study
British Journal of Urology International; 102(10):1432-1438, 2008 (IF 2,704)

 Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, Sroka R, Reich O
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
Laser Med Sci; 24(3):419-24, 2009 (IF 1,675)

Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P
DNA integrity in plasma and serum of patients with malignant and benign diseases
Ann NY Acad Sci; 1137:162-170, 2008 (IF 2,303)

Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M, Khoder W, Fischer F, Stief C, Sroka R
High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex-vivo investigations on porcine kidneys and human cadaver prostates
Laser Med Sci; 24(2): 172-178, 2009 (IF 1,675)

Seitz M, Bayer T, Ruszat R, Tilki D, Bachmann A, Gratzke C, Schlenker B, Stief C, Sroka R, Reich O
Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations
British Journal of Urology International; 103(6):770-775, 2009 (IF 2,704)

Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, Bader M, Tilki D, Roosen A, Karl A, Reich O, Khoder W, Wyler S, Stief CG, Staehler M, Bachmann A
Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma
British Journal of Urology International; 104(4):470-5, 2009 (IF 2,704)

Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, Gasser TC, Reich O, Bachmann A
Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
British Journal of Urology International; 104(6):820-5, 2009 (IF 2,704)

Seitz M, Liedl B, Becker A, Gratzke C, Reich O, Stief C
Upper transverse scrotal approach for muscle- and nerve-sparing urethral stricture repair
World J Urol; 27(5):667-72 (IF 2,699)

Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knuechel R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief C
Photodynamic Diagnosis Using 5-Aminolevulinic Acid for the Detection of Positive Surgical Margins during Radical Prostatectomy in Patients with Carcinoma of the Prostate: A Multicentre, Prospective, Phase 2 Trial of a Diagnostic Procedure
European Urology; 55(6):1281-8, 2009 (IF 6,512)

Reich O, Schlenker B, Gratzke C, Tilki D, Riecken M, Stief C, Seitz M, Bachmann A
Plasma-Vaporisation of the prostate: Initial clinical results
European Urology; 2009 May 26. [Epub ahead of print] (IF 6,512)

Tilki D, Singer BB, Shariat SF, Behrend A, Fernando M, Irmak S, Buchner A, Hooper AT, Stief CG, Reich O, Ergün S
CEACAM1 – a novel urinary marker for bladder cancer detection
European Urology; 2009 May 28. [Epub ahead of print] (IF 6,512)

Seitz M, Gratzke C, Schlenker B, Buchner A, Karl A, Roosen A,  Singer B, Bastian P, Ergün S, Stief C, Reich O, Tilki D
Contrast-Enhanced Transrectal Ultrasound (CE-TRUS) with Cadence-Contrast Pulse Sequence (CPS) Technology for the Detection of Prostate Cancer
Urol Oncol; 2009 June 11. [Epub ahead of print] (IF 2,662)

Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P
Transient Receptor Potential A1 and Cannabinoid Receptor Activity in Human Normal and Hyperplastic Prostate: Relation to Nerves and Interstitial Cells
European Urology; 2009 Aug 28. [Epub ahead of print] (IF 6,512)

Tilki D, Zaak D, Trottmann M, Buchner A, Ekiz Y, Gerwens N, Schlenker B, Karl A, Walther S, Bastian PJ, Gratzke C, Tritschler S, Knüchel-Clarke R, Ergün S, Stief CG, Reich O*, Seitz M*
*Shared senior authorship
Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
World J Urol; 2009 Oct 22. [Epub ahead of print] (IF 2,699)

Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O
Clinical and pathological predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series
Urol Oncol; 2009 Oct 16. [Epub ahead of print] (IF: 2,662)

Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche H, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients
Journal of Urology; 183(1): 87-93, 2010 (IF 3,952)

Schlenker B, Tilki D, Gratzke C, Seitz M, Reich O, Schneede P, Stief CG, Hungerhuber E
Intermediate-differentiated invasive (pT1 G2) penile cancer – oncological outcome and follow-up
Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)

Schlenker B, Gratzke C, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Tilki D
Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow up.
Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)

Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, Tilki D, Reich O, Schneede P, Bartenstein P, Stief CG, Seitz M
Detection of Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma by 18F-Fluorodeoxyglucose PET/CT: A prospective single-center study
Urol Oncol; 2009 Dec 16. [Epub ahead of print] (IF 2,662)

Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C
Organ-preserving Nd:YAG laser therapy for penile carcinoma: long-term follow up
British Journal of Urology International; 2010 Jan 19. [Epub ahead of print] (IF: 2,704)

Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
Eur J Med Res; in press 2009 (IF: 1,040)

Schlenker B, Gratzke C, Seitz M, von Walter P, Tilki D, Reich O, Zaak D, Stief CG, Bader MJ
Minimizing complications during retropubic radical prostatectomy – is ureteral stenting necessary?
Eur J Med Res; in press 2009 (IF: 1,040)

Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche H, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients
Journal of Urology; in press 2009 (IF 3,952)

Tilki D*, Reich O*, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF
*Shared first authorship
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome
European Urology; 2010 Jan 20. [Epub ahead of print] (IF: 6,512)

Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Vincenzo Ficarra, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF
pT3 substaging is a prognostic indicator in lymph node negative urothelial carcinoma of the bladder
Journal of Urology; in press 2010. (IF: 3,952)

Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O*, Shariat SF*
*Shared senior authorship
Stage pT0 at radical cystectomy confers an improvement in survival: An international study of 4430 patients
Journal of Urology; in press 2010. (IF: 3,952)